Research Topics
| Anthony A BavrySummaryAffiliation: University of Florida Country: USA Publications
| Collaborators
|
Detail Information
Publications
Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular eventsKi Park
Division of Cardiovascular Medicine, University of Florida, 1600 SW Archer Road, Box 100277, Gainesville, FL 32610
Cleve Clin J Med 80:318-26. 2013..Recent studies have provided insight into the risks of aspirin use, particularly bleeding, compared with its benefits in these subgroups...
Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudyAnthony A Bavry
Division of Cardiovascular Medicine, University of Florida, 1600 SW Archer Rd, PO Box 100277, Gainesville, FL 32610 0277, USA
Hypertension 55:48-53. 2010..PAD patients displayed a J-shape relationship with systolic blood pressure and the primary outcome, although individuals without PAD did not. PAD patients may require a different target blood pressure than those without PAD...- Harmful effects of NSAIDs among patients with hypertension and coronary artery diseaseAnthony A Bavry
Department of Medicine, College of Medicine, University of Florida, Gainesville, 32610 0277, USA
Am J Med 124:614-20. 2011..There is limited information about the safety of chronic nonsteroidal anti-inflammatory drugs (NSAIDs) in hypertensive patients with coronary artery disease... - Paving the coronaries with stents: okay in acute coronary syndromes?Anthony A Bavry
Clin Cardiol 34:141-2. 2011 - Efficacy and safety of unfractionated heparin plus glycoprotein IIb/IIIa inhibitors during revascularization for an acute coronary syndrome: a meta-analysis of randomized trials performed with stents and thienopyridinesDavid E Winchester
Department of Medicine, Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida 32610, USA
Clin Cardiol 35:93-100. 2012..Early studies of glycoprotein IIb/IIIa inhibitors (GPIs) demonstrated benefit during percutaneous coronary intervention for acute coronary syndromes (ACS). Since their introduction, the magnitude of benefit of GPIs has become unclear... - Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery diseaseRhonda M Cooper-Dehoff
Department of Pharmacotherapy and Translational Research and Division of Cardiovascular Medicine, College of Pharmacy, University of Florida, 1600 SW Archer Rd, PO Box 100486, Gainesville, FL 32610 0486, USA
JAMA 304:61-8. 2010..Hypertension guidelines advocate treating systolic blood pressure (BP) to less than 130 mm Hg for patients with diabetes mellitus; however, data are lacking for the growing population who also have coronary artery disease (CAD)... - Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudyScott J Denardo
Division of Cardiovascular Medicine, College of Medicine, University of Florida, Gainesville, FL 32610, USA
Am J Med 123:719-26. 2010..Our understanding of the growing population of very old patients (aged >or=80 years) with coronary artery disease and hypertension is limited, particularly the relationship between blood pressure and adverse outcomes... - Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: a meta-analysis of randomized trials performed in the era of stents and thienopyridinesDavid E Winchester
Department of Medicine, University of Florida, Gainesville, FL, USA
J Am Coll Cardiol 57:1190-9. 2011..The purpose of this study was to investigate the efficacy and safety of glycoprotein IIb/IIIa inhibitors (GPIs) during elective percutaneous coronary intervention (PCI)... - An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)Matheen A Khuddus
Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, Florida, USA
J Interv Cardiol 23:511-9. 2010..Information about the presence and characteristics of coronary atherosclerosis in these women could provide insight into the mechanisms related to increased risk, as well as improved diagnosis, prevention, and treatment... - Evidence of pre-procedural statin therapy a meta-analysis of randomized trialsDavid E Winchester
University of Florida, Gainesville, USA
J Am Coll Cardiol 56:1099-109. 2010..The purpose of this study was to summarize the evidence of pre-procedural statin therapy to reduce periprocedure cardiovascular events... - Acute myocardial infarction during infusion of liposomal doxorubicin for recurrent breast cancerDavid E Winchester
Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida 32610 0277, USA
Breast J 16:313-4. 2010..To our knowledge, this is the first report of an angiographically proven infarction temporally related to exposure to this chemotherapeutic agent... - Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trialsAnthony A Bavry
Department of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA
Eur Heart J 29:2989-3001. 2008..This study sought to determine whether the use of a thrombectomy or embolic protection device during revascularization for acute myocardial infarction reduces mortality compared with percutaneous coronary intervention (PCI) alone...